Paloma Partners’s Ocugen OCGN Stock Holding History

Paloma Partners’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-33,642	Closed	-$111K	–	1542
2022 Q1	$111K	Buy	33,642 +19,065	+131%	+$67K	﹤0.01%	1555
2021 Q4	$66K	Buy	+14,577	New	+$110K	﹤0.01%	1812

Other funds holding OCGN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Paloma Partners's OCGN Position: Q2 2022 in Review

Paloma Partners sold out of Ocugen (OCGN) in Q2 2022, closing a stake of 33,642 shares — an estimated $111K sold.

Paloma Partners first reported a position in OCGN in Q4 2021 and held it in 2 quarters. The position peaked at $111K in Q1 2022. 124 funds tracked by Wall St. Rank hold OCGN as of Q2 2022.

Paloma Partners reported no remaining Ocugen position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 33,642 Ocugen shares in Q2 2022, an estimated $111K.
Paloma Partners first reported a position in Ocugen in Q4 2021 and held it in 2 quarters.
Paloma Partners's Ocugen position peaked at $111K in Q1 2022.
124 funds tracked by Wall St. Rank held Ocugen as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.